Student-athlete perceptions of increased internationalization in college athletics

This study examined the effect of the increase in the number of international student-athletes in Division I college athletics on the experience of international and domestic student-athletes, specifically by investigating the perceptions of female athletes participating in sports that have high percentages of international student-athlete involvement. Scholarship opportunities, school choice, playing time, and recruiting areall areas that were explored through a questionnaire. This study potentially fills a gap in the research regarding the increased participation by international student-athletes on both the domestic and international student-athlete experience. Results indicated that international and domestic student-athletes had different perceptions of their recruiting experience than student-athletes of the opposite status, and further, different factors were important in terms of school choice. Both domestic and international student-athletes believed that there were similar scholarship opportunities in their sport, regardless of status, and further, that their sport had a high number of international participants

Florida Institute of Technology Ordered to Reinstate Men\u27s Rowing after Title IX Complaint

In February 2023, the U.S. District Court in Florida issued a preliminary injunction in favor of six male student-athletes from Florida Institute of Technology who alleged that the university violated Title IX. The male student-athletes filed the lawsuit against Florida Institute of Technology (FIT) in 2022. The student-athletes claimed FIT violated Title IX when the university eliminated rowing and other programs

Title IX at 50: Exploring the Impact of the Law on Cases of Sexual Misconduct and Participation Equity in Athletics

June 23, 2022 will mark the 50th anniversary of Title IX; during that time frame there has been a drastic increase in girl’s and women’s participation in sport. There has also been significant political debate and push back to Title IX which has threatened to undermine the impact of the law. Over the last 10 years, Title IX has been synonymous with litigation related to sexual harassment and transgender athlete participation in sport. Additionally, universities have continually sought to cut women’s sports under the guise of budgetary constraints. The purpose of this poster presentation is three-fold: 1) Review recent case developments in terms of cutting women’s sports; 2) emphasize that procedurally, sexual harassment and misconduct claims are in flux across campuses; and 3) discuss the current state of transgender athlete participation policies in sports

Terminated ASU Women\u27s Lacrosse Coach Files Retaliation and Wrongful Termination Lawsuit

Courtney Connor, the former women’s lacrosse coach at Arizona State University, sued the University and the Arizona Board of Regents (collectively, “ASU”) for Title VII and Title IX retaliation, as well as wrongful termination

Myonecrosis in Sickle Cell Anemia—Overlooked and Underdiagnosed

Medical literature detailing muscular complications of sickle cell anemia is sparse and limited to a few case-reports. Features consistent with myositis and myonecrosis are often overlooked and patients are inadequately treated, leading to unforeseen complications. We report an interesting case of sickle cell myonecrosis and review the existing literature on this subject

College Student Perceptions of Professional Development Through Sport Management Club Participation

Background Literature Traditionally, college students engaged in learning within the classroom setting. Research indicates that students can also learn in extracurricular activities such as internships and student clubs (Brown & Johnson, 2018). While research in the field of sport management has focused on the role of internships in professional development (e.g. Hayes & Mudrick, 2018; Young & Baker, 2004), less research has focused on the role of sport management clubs and how club participation may enhance a club member’s professional development. In addition, little research has focused on barriers that prevent students from joining. Purpose The purpose of this study was to examine student perceptions of the role that sport management clubs play in their professional development and barriers students face in joining those clubs. Research question What skills do students think sport management clubs help them build? What barriers prevent students from joining sport management clubs

Sport Management Clubs and Their Relationship to Sport Management Student Success

Participation in student-led sport management clubs can be beneficial for college students who are pursing sport management careers. These clubs can help give students the development and networking tools needed for success in the sport industry. The purpose of this presentation is to discuss the role and benefits of sport management clubs at three universities across three NCAA divisions, with a focus on networking, fundraising, event planning, and professional development. Our discussion will also include specific events that our students have completed as well as how the clubs provide students with opportunities to develop the skills and abilities to succeed in the sport industry

Failure of a non-authorized copy product to maintain response achieved with imatinib in a patient with chronic phase chronic myeloid leukemia: a case report

<p>Abstract</p> <p>Introduction</p> <p>Due to high rates of response and durable remissions, imatinib (Glivec^®, or Gleevec^® in the USA; Novartis Pharma AG) is the standard of care in patients with chronic myeloid leukemia. Recently, a non-authorized product which claims comparability to imatinib has become available.</p> <p>Case presentation</p> <p>This report describes the loss of response in a 36-year-old male patient with chronic-phase chronic myeloid leukemia who had previously been in full hematologic and cytogenetic remission and partial molecular remission for three years, under treatment with brand-name imatinib of 400 mg per day. Before the initiation of treatment with a copy product, imatib (CIPLA-India), the patient had negative BCR-ABL status. Within three months of initiation of treatment with the copy product, the patient's BCR-ABL status became positive, with substantial decreases noted in white blood cell counts, red blood cell counts and platelet counts. Conversion of the BCR-ABL status to negative and improvements in hematologic parameters were achieved when the brand medication, imatinib, was resumed at a dose of 600 mg per day.</p> <p>Conclusion</p> <p>In our patient, the substitution of a copy product for imatinib resulted in the rapid loss of a previously stable response, with the risk of progression to life-threatening accelerated phase or blast crisis phase of the disease. Without supportive clinical evidence of efficacy and safety of imatib (or any other copy product) caution should be used when substituting imatinib in the treatment of any patient with chronic myeloid leukemia.</p

Secondary Primary Malignancies in Multiple Myeloma: An Old Nemesis Revisited

The treatment of myeloma has undergone extraordinary improvements in the past half century. These advances have been accompanied by a concern for secondary primary malignancies (SPMs). It has been known for decades that extended therapy with alkylating chemotherapy agents, such as melphalan, carries an increased risk of therapy-related myelodysplastic syndrome and/or acute myeloid leukemia (t-MDS/AML), with a cumulative risk as high as 10–15%. High-dose chemotherapy with autologous stem cell support became widely accepted for myeloma in the 1990s. Despite the use of high doses of melphalan, the risk of t-MDS/AML with this procedure is estimated to be less than 5%, with much of this risk attributable to pretransplant therapy. Recently, lenalidomide has come under scrutiny for its possible association with SPMs. It is too soon to declare a causal relationship at this time, but there appears to be an increased number of SPMs in reports from several studies using lenalidomide maintenance. Current studies should be amended and future studies planned to better define the risk of SPMs and the risk factors and mechanisms for its development. Patients should be educated regarding this potential concern but the current use of lenalidomide should not generally be altered until further data are available